Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
HUMA Humacyte
- 1.460
- +0.020+1.39%
Close Apr 28 16:00 ET
226.47MMarket Cap-1.16P/E (TTM)
1.505High1.430Low1.33MVolume1.460Open1.440Pre Close1.94MTurnover1.08%Turnover RatioLossP/E (Static)155.12MShares9.97052wk High-4.29P/B180.24MFloat Cap1.15052wk Low--Dividend TTM123.45MShs Float17.450Historical High--Div YieldTTM5.21%Amplitude1.150Historical Low1.463Avg Price1Lot Size
About Humacyte Company
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Company Profile
SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
Founded2004
CEODr. Laura E. Niklason, M.D.,PhD
MarketNASDAQ
Employees220
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633
Websitehttp://humacyte.com
Company Executives
- Name
- Position
- Salary
- Dr. Laura E. Niklason, M.D.,PhD
- President, Chief Executive Officer and Director
- 2.63M
- William John Scheessele
- Chief Commercial Officer
- --
- Shamik J. Parikh
- Chief Medical Officer
- --
- Dr. Yang Cao
- Chief Regulatory Officer
- --
- Dr. Heather Prichard
- Chief Operating Officer
- 1.27M
- Dale A. Sander
- Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
- 1.35M
- Kathleen Sebelius
- Chairman of the Board
- 96.76K
- Rajiv Shukla
- Director
- 71.76K
- Brady W. Dougan
- Director
- 71.76K
- Gordon M. Binder
- Independent Director
- 71.76K
- Diane Seimetz, PhD
- Independent Director
- 71.76K
- Todd M. Pope
- Independent Director
- 76.76K
- Michael T. Constantino
- Independent Director
- 79.26K
- C. Bruce Green, M.D.
- Independent Director
- 71.76K
- Dr. Susan Richards Windham-Bannister, PhD
- Independent Director
- 71.76K
- Dr. Max Wallace, J.D.
- Independent Director
- 76.76K
- Dr. Keith Anthony Jones, M.D.
- Independent Director
- --
- Dr. John P. Bamforth
- Independent Director
- --
- Dr. Emery N. Brown, M.D.,PhD
- Independent Director
- 71.76K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
